Italia markets close in 1 hour 4 minutes

FTSE MIB
34.544,78
-280,23(-0,80%)
Dow Jones
39.849,27
+42,50(+0,11%)
Nasdaq
16.770,65
-24,23(-0,14%)
Nikkei 225
38.946,93
-122,75(-0,31%)
Petrolio
79,20
-0,60(-0,75%)
Bitcoin EUR
65.037,54
+3.403,44(+5,52%)

NVCR Jan 2026 7.500 call

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

9,30

0,00

(0,00%)

In data: 11:38AM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in